These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25722476)

  • 1. National Institute for Health and Care Excellence 2014 guidance on cardiac implantable electronic devices: health economics reloaded.
    Leyva F; Plummer CJ
    Europace; 2015 Mar; 17(3):339-42. PubMed ID: 25722476
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
    Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
    Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
    Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry.
    Behar JM; Chin HM; Fearn S; Ormerod JO; Gamble J; Foley PW; Bostock J; Claridge S; Jackson T; Sohal M; Antoniadis AP; Razavi R; Betts TR; Herring N; Rinaldi CA
    JACC Clin Electrophysiol; 2017 Feb; 3(2):107-116. PubMed ID: 28280785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.
    DeVore AD; Al-Khatib SM
    JACC Heart Fail; 2019 Oct; 7(10):907-910. PubMed ID: 31521688
    [No Abstract]   [Full Text] [Related]  

  • 8. Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis?
    Boriani G
    Europace; 2015 May; 17(5):674-6. PubMed ID: 25805157
    [No Abstract]   [Full Text] [Related]  

  • 9. NICE guidelines for use of implantable cardioverter defibrillators.
    Saberwal B; Ahsan S
    Br J Hosp Med (Lond); 2015 Jun; 76(6):316-7. PubMed ID: 26053899
    [No Abstract]   [Full Text] [Related]  

  • 10. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
    Landolina M; Morani G; Curnis A; Vado A; D'Onofrio A; Bianchi V; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2017 Aug; 19(8):1349-1356. PubMed ID: 27702861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy.
    Bernard ML; Gold MR
    Heart Fail Clin; 2011 Apr; 7(2):241-50, ix. PubMed ID: 21439502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of battery longevity on costs and health outcomes associated with cardiac implantable electronic devices: a Markov model-based Monte Carlo simulation.
    Schmier JK; Lau EC; Patel JD; Klenk JA; Greenspon AJ
    J Interv Card Electrophysiol; 2017 Nov; 50(2):149-158. PubMed ID: 29110166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitachycardia and resynchronization devices in the treatment of heart failure and prevention of sudden death].
    Sapel'nikov OV; Latypov RS; Grishin IR; Mareev IuV; Saidova MA; Akchurin RS
    Kardiologiia; 2011; 51(9):60-7. PubMed ID: 21943010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When cardiac resynchronization therapy may be harmful: time to wake up.
    Linde C
    Europace; 2015 Feb; 17(2):171-3. PubMed ID: 25345830
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in Older Adults With Heart Failure.
    Sandhu A; Levy A; Varosy PD; Matlock D
    J Am Geriatr Soc; 2019 Oct; 67(10):2193-2199. PubMed ID: 31403714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.
    Groeneveld PW; Dixit S
    Annu Rev Med; 2017 Jan; 68():1-13. PubMed ID: 27686020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis.
    Crespo C; Linhart M; Acosta J; Soto-Iglesias D; Martínez M; Jáuregui B; Mira Á; Restovic G; Sagarra J; Auricchio A; Fahn B; Boltyenkov A; Lasalvia L; Sampietro-Colom L; Berruezo A
    Eur J Prev Cardiol; 2020 Apr; 27(6):622-632. PubMed ID: 31487998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the underutilization of cardiac resynchronization therapy.
    Bank AJ; Gage RM; Olshansky B
    J Card Fail; 2014 Sep; 20(9):696-705. PubMed ID: 24948569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.